Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
13,671,920
-
Share change
-
+25,138
-
Total reported value
-
$3,104,685,868
-
Put/Call ratio
-
236%
-
Price per share
-
$227.06
-
Number of holders
-
277
-
Value change
-
+$5,715,743
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2013
As of 31 Dec 2013,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
277 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,671,920 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS AG, BARCLAYS PLC, CHURCHILL MANAGEMENT Corp, BANK OF NOVA SCOTIA /, DEUTSCHE BANK AG\, and JPMORGAN CHASE & CO.
This page lists
277
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.